Doctor insights on:
Zytiga (abiraterone acetate) or xtandi for pre-chemo castration resistant prostate cancer? Thoughts?
Immune booster: Provenge (sipuleucel-t) is designed to train your body's immune system to recognize an attack your cancer cells. In a large controlled trial, Provenge (sipuleucel-t) was shown to improve overall survival by 4.1 months. There was a 22.5% improvement in survival with the use of this vaccine. It is indicated for patients with metastatic prostate cancer whose disease has progressed despite hormone therapy. ...Read moreSee 1 more doctor answer
Same drugs as other: Same chemotherapy drugs are used for treating both types of colon cancer. The only difference is lack of benefit from EGFR inhibitors(Cetuximab and Panitumumab). Avastin (bevacizumab) also works in both types. I trust that you know there are 3 chemo drugs that are widely used(5FU or Capecitabine, Irinotecan and Oxaliplatin) ...Read more
Diagnoged with cutaneous tcell lymphoma nhl.Treated with eletron beam.Interferon, gemcitabine, anthracycline, etoposide, procarbazine.Nodules over body .?
Xeloda (capecitabine) for breast ca: Xeloda (capecitabine) also known as Capecitabine is a very effective oral chemotherapy drug used for metastatic or stage 4 breast cancer. It can be used by itself (mono therapy) or as part of combination chemotherapy. Major side effects include diarrhea, hand foot syndrome, nausea and small chance of coronary spasm. It is well tolerated. Patients on Xeloda (capecitabine) need to be followed closely by medical oncologists. ...Read moreSee 1 more doctor answer
Many: The side effects are too many to list here but some of the more common ones (occur in >10% of patients) are fever, fatigue, headache, insomnia, depression, emotional lability, rash, nausea, diarrhea, weight loss, anemia, muscle aches, joint pains, flu-like syndrome and injection site reations. ...Read more
Yes they can be: The evidence is stronger for beta interferons (avonex, Rebif and betaseron) than it is for immuran. Interferons are fda approved and immuran is not (for ms) they all have a modest but definite effect in reducing the number of attacks in remitting relapsing forms the effect varies from patient to patient. ...Read moreSee 2 more doctor answers
See answer below: Both are used in rrms with similar efficacy levels. Copaxone (glatiramer) does not need blood monitoring and is administered as a subcutaneous sc injection daily. Side effects include injection site reactions. Interferons need lab work monitoring, can be a weekly injection into a muscle (avonex), every other day sc (betaseron) or three times a week sc (rebif). Most commo side effects include flu-like symptoms. ...Read more
It has generated exc: Immunotherapy is a new area of treatments for Cancer, different than the Targeted therapies of the last 15 years. It has excellent anticancer activity(in Lung Cancer+ more) It works on the human immune system, thus it is not targeted at the Cancer cells but at the immune cells called Lymphocytes which have the ability to kill cancer cells when properly stimulated with the modern immunotherapy drug ...Read more
Probably never will: Many of the drugs we use in pediatric oncology are never approved by the fda for treatment of a particular pediatric cancer. Once it gains fda approval for an adult disease indication, we then can study it in clinical trials, and if warranted, use it. ...Read moreSee 3 more doctor answers